BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1675 related articles for article (PubMed ID: 30208379)

  • 1. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of idiopathic inflammatory myopathies: pathology perspectives.
    Tanboon J; Nishino I
    Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where are we moving in the classification of idiopathic inflammatory myopathies?
    Tanboon J; Uruha A; Stenzel W; Nishino I
    Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
    Inoue M; Nishino I
    Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and classification of idiopathic inflammatory myopathies.
    Lundberg IE; Miller FW; Tjärnlund A; Bottai M
    J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
    Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
    Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in serological diagnostics of inflammatory myopathies.
    Benveniste O; Stenzel W; Allenbach Y
    Curr Opin Neurol; 2016 Oct; 29(5):662-73. PubMed ID: 27538058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autoantibody profile in myositis].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
    J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
    Allenbach Y; Benveniste O
    Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.